SCHEMBL19628146

SCHEMBL19628146

c1ccc(-c2cc(-c3ccccc3)cc(-c3cc4cccc5c6c7ccccc7sc6c6cccc3c6c45)c2)cc1

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TNKS O95271 2/20 0.35
TNKS2 Q9H2K2 2/20 0.35
ALOX5 P09917 1/20 0.35
CYP1A1 P04798 1/20 0.33
CYP1B1 Q16678 1/20 0.33
PTPN1 P18031 1/20 0.33
F9 P00740 1/20 0.33
MAPT P10636 3/20 0.33
MEN1 O00255 3/20 0.33
KMT2A Q03164 3/20 0.33
ALDH1A1 P00352 3/20 0.33
HPGD P15428 3/20 0.33
KDM4E B2RXH2 2/20 0.33
MPI P34949 1/20 0.33
RAB9A P51151 1/20 0.32
HSD17B1 P14061 1/20 0.31
HSD17B2 P37059 1/20 0.31
ERBB2 P04626 1/20 0.31
CYP1A2 P05177 1/20 0.31
FYN P06241 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19628180 0.95 TNKS (0.33) TNKSTNKS2ALOX5CYP1A1CYP1B1
SCHEMBL19628140 0.93 MEN1 (0.38) TNKSTNKS2ALOX5CYP1A1CYP1B1
SCHEMBL19628169 0.90 CYP1A2 (0.35) TNKSTNKS2ALOX5CYP1A1CYP1B1
SCHEMBL19628163 0.90 PTPN1 (0.38) TNKSTNKS2ALOX5CYP1A1CYP1B1
SCHEMBL19628178 0.88 MEN1 (0.35) TNKSTNKS2ALOX5CYP1A1CYP1B1
SCHEMBL19628175 0.85 PTPN1 (0.37) TNKSTNKS2ALOX5CYP1A1CYP1B1
SCHEMBL19628142 0.84 ADORA2A (0.35) TNKSTNKS2ALOX5CYP1A1CYP1B1
SCHEMBL19628134 0.84 ALOX5 (0.36) TNKSTNKS2ALOX5MEN1KMT2A
SCHEMBL19628153 0.84 ALOX5 (0.41) TNKSTNKS2ALOX5MEN1KMT2A
SCHEMBL19628185 0.84 ALOX5 (0.41) TNKSTNKS2ALOX5F9ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10439144-B2 Organic compound for electronic device comprising fused-core structure, organic optoelectronic device comprising same, and display device UNIVERSITY-INDUSTRY COOPERATEON GROUP OF KYUNG HEE UNIVERSITY (KR) 2019-10-08 US disclosed
US-20170338416-A1 ORGANIC COMPOUND FOR ELECTRONIC DEVICE COMPRISING FUSED-CORE STRUCTURE, ORGANIC OPTOELECTRONIC DEVICE COMPRISING SAME, AND DISPLAY DEVICE UNIVERSITY-INDUSTRY COOPERATION GROUP OF KYUNG HEE UNIVERSITY (KR) 2017-11-23 US disclosed
US-20170338416-A1 ORGANIC COMPOUND FOR ELECTRONIC DEVICE COMPRISING FUSED-CORE STRUCTURE, ORGANIC OPTOELECTRONIC DEVICE COMPRISING SAME, AND DISPLAY DEVICE UNIVERSITY-INDUSTRY COOPERATION GROUP OF KYUNG HEE UNIVERSITY (KR) 2017-11-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10439144-B2 Organic compound for electronic device comprising fused-core structure, organic optoelectronic device comprising same, and display device OR10J3, OCIAD2, OCIAD1 TNKS 4514/4885TNKS2 4597/4885ALOX5 1129/4885
US-20170338416-A1 ORGANIC COMPOUND FOR ELECTRONIC DEVICE COMPRISING FUSED-CORE STRUCTURE, ORGANIC OPTOELECTRONIC DEVICE COMPRISING SAME, AND DISPLAY DEVICE OR10J3, OCIAD2, OCIAD1 TNKS 4514/4885TNKS2 4597/4885ALOX5 1129/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.